oligomers changes
individual oligomers
neurodegenerative disease
human disease
Characterising protein oligomers
low concentration of oligomers
stem cell models of Alzheimer’s disease
structure
spreading
ultrasensitive methods
clinical samples of CSF
onset
Parkinson’s diseases
patients
composition
detectable changes
capability
samples of brain tissue
key role
oligomer size
major roles
major advance
increased cytotoxicity
early diagnosis
humans Small soluble protein aggregates
proteinase
resistance
mass spectrometry
translational modifications
targets
genetic mutations
therapies
number
detection
results
unprecedented level
mechanism of damage
field
problem
fluorescence
project
characterisation
end
experiments